naxagolide has been researched along with colforsin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hutson, PH; Suman-Chauhan, N | 1 |
| Login, IS; Trugman, JM | 1 |
2 other study(ies) available for naxagolide and colforsin
| Article | Year |
|---|---|
Activation of postsynaptic striatal dopamine receptors, monitored by efflux of cAMP in vivo.
Topics: Animals; Benzazepines; Colforsin; Corpus Striatum; Cyclic AMP; Desipramine; Dopamine Agents; Hydroxydopamines; Kinetics; Male; Oxazines; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Synapses | 1990 |
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
Topics: Angiotensin II; Animals; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Antagonists; Female; Haloperidol; In Vitro Techniques; Oxazines; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1989 |